- 24 h
- 7 Tage
- 14 Tage
- 6 Monate
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 05:10 | RemeGen shares trade over 9% amid AbbVie licensing deal | 4 | China Daily | ||
| 05:06 | AbbVie secures tariff relief in drug pricing deal, pledges $100B investment | 5 | Seeking Alpha | ||
| 04:47 | UBS Expects WUXI BIO Rev. to Grow 17% YoY This Yr | 3 | AASTOCKS | ||
| 03:26 | Nvidia to invest US$1 billion in AI drug laboratory with Eli Lilly | 4 | Financial Post | ||
| 03:17 | REMEGEN Once Spikes 14%+ After Granting AbbVie Exclusive License for RC148 | 2 | AASTOCKS | ||
| 02:38 | Nvidia, Lilly to invest up to $1B in new AI medical research lab | 4 | SiliconANGLE | ||
| 02:35 | Merck says new growth opportunities to drive revenue of $70 billion by mid-2030s | 3 | Reuters | ||
| 02:33 | MAYNE PHARMA GROUP LIMITED: Becoming a substantial holder from MUFG | 1 | ASX | ||
| 02:00 | AbbVie Commits $100 Bln To U.S. Innovation, Pledges Lower Medicaid Drug Prices | 272 | AFX News | WASHINGTON (dpa-AFX) - AbbVie (ABBV) announced that it has entered into an agreement with the Trump administration aimed at expanding access and affordability for Americans while safeguarding... ► Artikel lesen | |
| 01:46 | AbbVie Puts Up $650M to Join Emerging But Crowded Area of Cancer Drug R&D | 4 | MedCity News | ||
| 01:35 | Pfizer CEO plans for soaring consumer market for obesity drugs akin to Viagra | 2 | Reuters | ||
| 01:18 | Captiva Verde Wellness Corp: Captiva to open atmospheric water station in Florida | 1 | Stockwatch | ||
| 01:06 | Zyus Life Sciences Corp: Zyus Life Sciences arranges $16-million financing | 1 | Stockwatch | ||
| 01:02 | CannaPharmaRX Provides Corporate Update and Outlines Growth Strategy for 2026 | 293 | ACCESS Newswire | CALGARY, AB / ACCESS Newswire / January 12, 2026 / CannaPharmaRX, Inc. (OTC PINK:CPMD), an emerging leader in global cannabis cultivation and export, is pleased to provide a corporate update outlining... ► Artikel lesen | |
| 00:42 | AbbVie strikes deal with Trump administration on drug pricing | 3 | Investing.com | ||
| 00:26 | UBS Likes Pfizer's MTSR Obesity Deal but Stays Neutral on PFE | 5 | Insider Monkey | ||
| 00:14 | Faruqi & Faruqi LLP: UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience | 272 | Newsfile | Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Skye To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired... ► Artikel lesen | |
| Mo | JPM26: US biotech's 'Sputnik moment,' Pfizer's obesity ambitions and Bristol Myers' big year | 3 | BioPharma Dive | ||
| Mo | Grace Therapeutics passt Abfindungsregelungen für Führungskräfte an | 1 | Investing.com Deutsch | ||
| Mo | Predictmedix AI Inc: Predictmedix to change name to QScreen AI | 2 | Stockwatch |
1 2 3 4 5 Weiter >>
- 24 h
- 7 Tage
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | Aktuelle Nachrichten | |||
|---|---|---|---|---|---|---|---|
| ELI LILLY | 31 | 125 | +0,27 % | MEDICAL BioHealth Fonds: Eli Lilly kauft Ventyx Biosciences | Gräfelfing (www.fondscheck.de) - Anbei eine aktuelle Pressemitteilung der Medical Strategy GmbH:Zum Kauf von Ventyx Biosciences durch Eli Lilly ein Statement von Mario Linimeier, Geschäftsführer der... ► Artikel lesen | ||
| ABBVIE | 19 | 55 | -0,11 % | Börsenfrühstück: Defense, AbbVie, Micron & Exxon | Marktbeicht für den 08.01.2026: Die internationalen Aktienmärkte zeigen sich nach dem starken Jahresstart uneinheitlich. In den USA schloss der S&P 500 am Mittwoch leicht im Minus, während der Nasdaq... ► Artikel lesen | ||
| ALNYLAM PHARMACEUTICALS | 14 | 9 | -0,25 % | Alnylam Unveils 'Alnylam 2030' Strategy To Drive Growth And Innovation | WASHINGTON (dpa-AFX) - Alnylam Pharmaceuticals, Inc. (ALNY) announced its new five-year strategy, 'Alnylam 2030.' The plan is designed to scale the company's operations by achieving leadership... ► Artikel lesen | ||
 | NOVO NORDISK | 12 | 40 | +0,10 % | Märkte am Morgen: Siemens, Nvidia, Microchip Technology, Novo Nordisk, Adidas, Bayer | Der DAX hat in dieser Woche bisher Stärke gezeigt und den geopolitischen Ereignissen damit getrotzt. Sowohl am Montag als auch gestern erreichte er neue Bestmarken. Auch heute deuten sich Gewinne an.... ► Artikel lesen | |
| PFIZER | 10 | 92 | +0,09 % | Unrechtmäßige Milliarden-Umsätze? Bayer verklagt Biontech, Pfizer und Moderna wegen mRNA-Patenten | Der Pharmakonzern Bayer wirft Biontech, Pfizer und Moderna vor, eine alte Monsanto-Technologie genutzt haben, um ihre mRNA-Impfstoffe herzustellen - und will deshalb vor einem US-Gericht Schadenersatz... ► Artikel lesen | ||
| TEVA | 10 | 21 | -0,35 % | Royalty Pharma And Teva Broaden Collaboration To Advance Potential Vitiligo Treatment | WASHINGTON (dpa-AFX) - Royalty Pharma plc. (RPRX) and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), have announced a funding agreement of up to $500 million... ► Artikel lesen | ||
| BAYER | 7 | 36 | +2,13 % | Eilmeldung am Abend: BAYER AG zeigt unerwartete Stärke | |||
| BRISTOL-MYERS SQUIBB | 7 | 23 | -0,13 % | JPM26: US biotech's 'Sputnik moment,' Pfizer's obesity ambitions and Bristol Myers' big year | |||
| AVADEL PHARMACEUTICALS | 7 | 6 | 0,00 % | Avadel Pharmaceuticals plc: Avadel Pharmaceuticals Announces that Avadel Shareholders Approve the Proposed Acquisition by Alkermes | |||
| JAZZ PHARMACEUTICALS | 6 | 1 | -0,78 % | Boehringer Ingelheim Limited: Boehringer Ingelheim announces clinical collaboration with Jazz Pharmaceuticals to advance HER2-targeted therapy in breast cancer | Phase 1b study to evaluate combination of zongertinib and zanidatamab in HER2-positive breast cancer patients
Ingelheim, Germany- 12 January, 2026 - Boehringer Ingelheim today announced a strategic... ► Artikel lesen |
- Alle
| Unternehmen / Aktien | Aktueller Kurs | Ø Kursziel (Euro) | Potential (Euro) | kaufen | halten | verkaufen | |||
|---|---|---|---|---|---|---|---|---|---|
| PFIZER INC | 21,680 | 33,90 | +56 % | 3 | 8 | - | |||
| DOCMORRIS AG | 6,485 | 9,28 | +43 % | 3 | 2 | 3 | |||
| SCHOTT PHARMA AG & CO KGAA | 15,600 | 21,15 | +36 % | 7 | 6 | - | |||
| SANOFI SA | 81,91 | 101,75 | +24 % | 22 | 7 | - | |||
| MERCK KGAA | 131,25 | 141,17 | +8 % | 17 | 3 | - | |||
| ASTRAZENECA PLC | 162,85 | 172,60 | +6 % | 16 | 1 | 6 | |||
| NOVO NORDISK A/S | 51,47 | 50,91 | -1 % | 26 | 13 | 4 | ||
| NOVARTIS AG | 121,48 | 119,33 | -2 % | 10 | 10 | 1 | |||
| ROCHE HOLDING AG GS | 367,25 | 352,70 | -4 % | 10 | 13 | 13 | |||
| DERMAPHARM HOLDING SE | 37,900 | 34 | -10 % | - | 2 | - | |||
| BAYER AG | 39,710 | 35,50 | -11 % | 9 | 17 | - | |||
| GSK PLC | 21,630 | 18,12 | -16 % | 6 | 15 | 7 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .